Cost-effectiveness analysis of cetuximab combined with chemotherapy as a first-line treatment for patients with RAS wild-type metastatic colorectal cancer based on the TAILOR trial

by Huijuan Wang, Lingfei Huang, Zhengyi Zhu, Weifeng Ye, Haiying Ding, Luo Fang
Published 2020-02-01

Correction: Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients wit...

by Huijuan Wang, Lingfei Huang, Zhengyi Zhu, Weifeng Ye, Haiying Ding, Luo Fang
Published 2020-02-01

Up-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and ORC1

by Xing Chen, Dongsheng Xiong, Liya Ye, Kai Wang, Lingfei Huang, Shuangshuang Mei, Jinhong Wu, Shanshan Chen, Xiaoli Lai, Lingzhi Zheng, Meifen Wang
Published 2019-02-01